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        Introduction 
  Mechanical force regulates a variety of physiological processes 
involved in cellular functions, development of tissues and organs, 
and the health of an organism (  Orr et al., 2006  ). Although the 
mechanisms by which cells sense and convert mechanical force 
into intracellular biochemical signals have been a subject of 
keen interest, the problem is not easy to approach experimen-
tally. However, some experimental systems have been devel-
oped in recent years to study specifi  c mechanotransduction 
pathways. For example, Sheetz and his associates made detergent-
extracted cell models and in vitro protein extension systems 
that can elicit certain mechanoresponses and be analyzed bio-
chemically (  Sawada and Sheetz, 2002  ;   Tamada et al., 2004  ; 
  Sawada et al., 2006  ). We, and others, have attached microbeads 
coated with either antibodies or ligands specifi  c for cell sur-
face proteins onto cultured cells and mechanically stimulated 
the cells by tugging on the beads (  Osawa et al., 2002  ;   Tzima 
et al., 2005  ;   Wang et al., 2005  ). These studies are beginning to 
reveal molecular mechanisms for mechanotransduction by 
specifi  c proteins. 
 Endothelial cells (ECs) are known to respond to fl  uid shear 
stress and mechanical stretch and are regarded as one of the best 
known mammalian cell systems for studying mechanotransduc-
tion. Ion channels, integrins, glycocalyx, and G protein – coupled 
receptors are thought to be involved in fl  uid shear stress sensing 
by ECs because either fl  ow provokes their activities or disrup-
tion of their function down-regulates certain fl  ow-dependent 
responses (  Davies, 1995  ;   Resnick et al., 2003  ;   Li et al., 2005  ). 
However, it remains largely unknown how these molecules con-
vert mechanical force into intracellular signaling. Platelet EC 
adhesion molecule 1 (PECAM-1) is a cell adhesion molecule 
localized to interendothelial contacts. It forms trans-homophilic 
associations extracellularly and contributes to the formation and 
maintenance of an EC monolayer. In addition to being a cell 
adhesion molecule, it appears to have roles in cell signaling, 
as its short cytoplasmic domain contains two immunoreceptor 
tyrosine-based inhibitory motifs (ITIMs), a motif known to be 
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To investigate if Fyn was also involved in stretch-induced 
PECAM-1 phosphorylation in intact ECs, we stretched ECs 
treated with Fyn, Src, or Yes siRNA and found that PECAM-1 
phosphorylation was inhibited only by Fyn siRNA. PECAM-1 
phosphorylation by flow was also inhibited by Fyn siRNA. 
Identifi  cation of Fyn as the kinase for mechanical force-elicited 
PECAM-1 phosphorylation provides signifi  cant insights into 
PECAM-1 – dependent  mechanosignaling  in  ECs. 
  Results 
  Stretch-induced PECAM-1 tyrosine 
phosphorylation in live and detergent-
extracted ECs 
 Confl  uent ECs were cultured on an elastic silicone membrane 
that was uniaxially extended by 5  –  25% of the original length, 
causing the cells to be stretched. Increased protein tyrosine 
phosphorylation, a hallmark of signaling activity, became detect-
able within a few minutes of stretch, peaked at 10 min, and then 
gradually diminished (Fig. S1, available at http://www.jcb.org/
cgi/content/full/jcb.200801062/DC1). When ECs were stained 
with anti  –  protein phosphotyrosine (4G10), interendothelial con-
tacts of stretched cells became more prominently stained (  Fig. 1 A  ), 
suggesting that cell  –  cell contacts are a major stretch-induced 
mechanosignaling site. Initially, experiments were done using 
cyclic stretch, but this creates movement of the culture medium, 
causing cells to be exposed to both fl  uid shear stress and stretch. 
To avoid this situation, we used a single sustained stretch where 
the silicon membrane remained stretched throughout the experi-
ment. The membrane was stretched gently so that the shear effect 
would be small. For example, we took 3 s to stretch the chamber 
by 7.5 mm (25% stretch), thus exposing cells to a fl  ow velocity 
of 2.5 mm/s at the beginning of stretch experiments. Although 
data from cyclic stretch experiments were more variable, cells 
responded to both forms of stretch in a similar manner (Fig. S2). 
The data illustrated are from sustained stretch experiments un-
less otherwise stated. 
involved in signaling (  Woodfi  n et al., 2007  ). When the tyrosine 
residue in the ITIM is phosphorylated, it associates with SHP-2 
(SH2 domain  –  containing protein tyrosine phosphatase) and ac-
tivates the extracellular signal-regulated kinase (ERK) signal-
ing pathway (  Milarski and Saltiel, 1994  ;   Jackson et al., 1997  ). 
We have found that when cultured ECs are exposed to physio-
logical levels of shear stress, PECAM-1 ITIMs are phosphory-
lated and that this phosphorylation mediates ERK activation by 
fl  uid shear stress (  Masuda et al., 1997  ;   Osawa et al., 2002  ;   Tai 
et al., 2005  ). Interestingly, these shear stress  –  dependent responses 
occur when a pulling force is applied directly to PECAM-1 on 
the cell surface using magnetic beads coated with antibodies 
against the external domain of PECAM-1 (  Osawa et al., 2002  ). 
This experiment suggests that PECAM-1 responds directly to 
mechanical force, transducing mechanical force into a biochem-
ical signal. Because PECAM-1 has no intrinsic kinase activity, 
some kinase must be involved in PECAM-1 phosphorylation, 
and identifying the kinase is essential to elucidating the mecha-
nism for PECAM-1 mechanotransduction. 
  The presence of a mechanotransducer protein complex at 
cell  –  cell contacts has been previously suggested (  Davies et al., 
2003  ;   Chiu et al., 2004  ;   Liebner et al., 2006  ), and PECAM-1 may 
be a key molecule in such a complex (  Osawa et al., 2002  ;   Bagi 
et al., 2005  ;   Tzima et al., 2005  ). We hypothesized that the kinase 
that phosphorylates PECAM-1 might be a component of such a 
complex. In this study, we made a detergent-extracted cytoskeletal 
model of EC monolayers that retained PECAM-1 localization 
at interendothelial contacts and investigated PECAM-1 tyrosine 
phosphorylation in it by stretch. We found that when the EC 
model was stretched in the presence of ATP, PECAM-1 was phos-
phorylated. Because PECAM-1 phosphorylation did not require 
exogenous kinase, the kinase that phosphorylated PECAM-1 
must be a component of the cell model. Using several inhibitors 
targeted to different sets of tyrosine kinases, we identifi  ed Src, 
Yes, and Fyn as possible PECAM-1 kinases. Then, we used a 
siRNA technique to show that Fyn, not Src and Yes, was the kinase 
required for PECAM-1 phosphorylation in stretched cell models. 
  Figure 1.       Stretch-induced PECAM-1 phos-
phorylation in intact ECs.   (A) Conﬂ  uent BAECs 
cultured on an elastic substrate were stretched 
(25% elongation) for 5 min or left unstretched 
and stained with anti  –  protein phosphotyrosine 
(4G10). Tyrosine phosphorylated proteins 
were associated with interendothelial contacts, 
but this localization pattern became more 
prominent in stretched cells. Bipolar arrow in-
dicates the direction of stretch. Bar, 20   μ  m. 
(B) Conﬂ   uent or sparse BAECs cultured on 
an elastic substrate were subjected to stretch 
(25% elongation) for the times indicated or left 
unstretched. PECAM-1 phosphorylation was 
analyzed by immunoprecipitating PECAM-1 
and immunoblotting with anti  –  PECAM-1 and 
4G10. Although PECAM-1 phosphorylation in-
creased in conﬂ  uent cells, no increase was ob-
served in sparse cultures. Black lines   indicate 
that intervening lanes have been spliced out. (C) Quantiﬁ  cation of immunoblotting results. Relative levels of PECAM-1 phosphorylation were determined 
by measuring the intensity of immunoblotted bands (see Materials and methods) and expressed relative to the phospho  –  PECAM-1 level in unstretched cells 
(mean   ±   SEM). Sample size:   n   = 6 for conﬂ  uent samples,   n   = 3 for sparse samples. Student  ’  s   t   test was used to compare each time point with unstretched 
sample for each category. *, P = 0.0007, 0.0006, and 0.0003 for 5, 10, and 15 min, respectively. #, P = 0.0733 (conﬂ  uent, stretched 2 min) and 
0.5077 (sparse, stretched 10 min).     755 FYN MEDIATES PECAM-1 MECHANOTRANSDUCTION   • Chiu et al. 
on cells with   <  5% stretch. Our studies appear to suggest that 
PECAM-1 phosphorylation is triggered by a simple mechanical 
process achievable by a 5% extension in length. Our results to-
gether show that, other than ATP, soluble components of the cell 
do not play a significant role in stretch-induced PECAM-1 
phosphorylation and that all proteins needed for this stretch 
response are in the model, presumably as a stable complex. 
Furthermore, they suggest that PECAM-1 phosphorylation by 
stretch is a mechanical phenomenon that does not require living 
cells. We hypothesized that the fundamental mechanism for 
mechanostimulus-dependent PECAM-1 phosphorylation was pre-
served in the model and that the kinase for this response was as-
sociated with the model. 
  From 244 known kinases to 3 candidates 
  Roughly a dozen kinases have been reported to phosphorylate 
PECAM-1 (  Lu et al., 1997  ;   Masuda et al., 1997  ;   Cao et al., 1998 ; 
  Cicmil et al., 2000  ;   Newman et al., 2001  ;   Ohmori et al., 2001  ; 
  Kogata et al., 2003  ) based on in vitro kinase assays and experi-
ments involving inhibitors, overexpression studies, and co-
immunoprecipitation, which may or may not refl  ect what happens 
  PECAM-1 is localized to interendothelial cell  –  cell con-
tacts (  Fig. 2 C  ). It is constitutively tyrosine phosphorylated at 
low levels, but when confl  uent ECs are stimulated by fl  ow or 
when PECAM-1 on the surface of sparsely cultured ECs is 
directly pulled, PECAM-1 tyrosine phosphorylation increases 
(  Osawa et al., 2002  ). Stretch is another form of mechanical stress 
and may also elicit PECAM-1 phosphorylation. Indeed, when 
bovine aortic ECs (BAECs) were stretched, PECAM-1 phosphory-
lation increased in confluent but not sparse cultures (  Fig. 1, 
B and C  ), indicating that this PECAM-1 mechanoresponse is cell  –
  cell contact  –  dependent or, in molecular terms, only PECAM-1 
that is externally engaged can respond to stretch. There was no 
statistical difference in phosphorylation levels at 5 min and 
after 5 min, indicating that the plateau is reached by 5 min. 
This PECAM-1 phosphorylation time course is similar to those 
by fl  ow and hyperosmotic shock (  Osawa et al., 1997  ). To show 
that this response was not limited to BAECs, we stretched 
human umbilical vein ECs (HUVECs) and human arterial ECs 
(HAECs) and observed that PECAM-1 in these cells also re-
sponded similarly (see  Figs. 4 D and 7 A ). If PECAM-1 phosphory-
lation is indeed a mechanical event, it might occur when an 
extracted cell model is stretched. 
 Confl  uent BAECs on a silicone substrate were extracted 
with Tris-buffered saline containing 0.1% Triton X-100 and 
stretched in the presence of ATP (  Fig. 2 A  ). By scanning elec-
tron microscopy, we observed exposed nuclei and a fi  lamentous 
meshwork in extracted cells (  Fig. 2 B  ). Roughly 70% of the cell 
protein was extracted, but     80% of PECAM-1 was retained in 
cell models of BAECs, HUVECs, and HAECs (Fig. S3, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200801062/DC1). 
When models were stained with anti  –  PECAM-1, a honeycomb 
pattern similar to that exhibited by unextracted ECs was observed 
(  Fig. 2 C  ). By immunofl  uorescence, VE-cadherin and    -catenin 
localization along the cell border and actin fi  laments of the cir-
cumferential ring appeared unaffected by the extraction (unpub-
lished data). 
  When EC models were stretched for up to 10 min in the 
presence of 0.5 mM ATP, 4G10 immunostaining along cell  –  cell 
contacts increased (  Fig. 3 A  ) and immunoblots with 4G10 re-
vealed a prominent 130-kD band (  Fig. 3 B  ). When cell models 
of BAECs whose PECAM-1 expression was down-regulated by 
siRNA were stretched, phosphorylation of this band was atte-
nuated (  Fig. 3 B  ), suggesting that the protein is PECAM-1. 
To specifi  cally analyze PECAM-1 phosphorylation in the model, 
PECAM-1 was immunoprecipitated and its phosphorylation as-
sayed by 4G10 immunoblotting. Both sustained (  Fig. 4 A  ) and 
cyclic (  Fig. 4 C  ) stretch augmented PECAM-1 phosphorylation 
in the BAEC model. Cell models of HUVECs and HAECs re-
sponded similarly to stretch ( Fig. 4 D ; and see  Fig. 6 B ). Stretch-
ing models without ATP did not appreciably phosphorylate 
PECAM-1 (  Fig. 4 A  ). To see if the plateau level of stretch-
induced PECAM-1 phosphorylation depended on the magnitude 
of stretch, models were stretched by 5 (lowest stretch obtainable 
by the apparatus), 10, 15, 20, and 25% (  Fig. 4 B  ) for 5 min. 
We found that 5% stretch was as effective as 25% stretch in 
phosphorylating PECAM-1. Because the stretch apparatus used is 
not designed to reliably stretch cells   <  5%, no analysis was done 
  Figure 2.       The detergent-extracted EC model.   (A) Schematic representa-
tion of the preparation and mechanical activation of the cell model. Conﬂ  u-
ent BAECs cultured on an elastic substrate were extracted brieﬂ  y with Triton 
X-100. The material remaining attached was considered   “  the extracted 
cell model  ”  . The model was subsequently incubated with buffer contain-
ing ATP and subjected to uniaxial stretch or left unstretched at 37  °  C. 
(B) Scanning electron micrographs showing the surface structure of intact 
cells and extracted cell models. Note that intracellular structures are ex-
posed in extracted cells (right), whereas smooth plasma membrane is 
seen in intact ECs (left). Bars: (top) 10   μ  m; (bottom) 1   μ  m. (C) Immuno-
ﬂ  uorescence localization of PECAM-1 in intact and extracted BAECs. Cell 
border localization of PECAM-1 is preserved in the model. Bar, 10   μ  m.     JCB • VOLUME 182 • NUMBER 4 • 2008  756
10   μ  M PP2, 1   μ  M SU6656, and 1   μ  M staurosporin (not de-
picted) but not 10   μ  M imatinib, 200   μ  M LFM-A13, and 1   μ  M 
VEGF receptor (VEGFR) kinase inhibitor inhibited PECAM-1 
phosphorylation by stretch. 
  Of all the inhibitors we used that blocked PECAM-1 
phosphorylation by stretch, the most complete effi  cacy data 
were available for PP2. Its effects on 244 known kinases (which 
also include 14 mutant kinase forms) were obtained from the 
following database: http://www.invitrogen.com/downloads/ 
SelectScreen_Data_193.pdf. Using this database, we identifi  ed 46 
kinases whose activity was inhibited by 60% or more by 10   μ  M 
PP2 (Table S1, available at http://www.jcb.org/cgi/content/full/
inside ECs under physiological conditions. It is possible that 
PECAM-1 is a promiscuous substrate, but it is also possible 
that kinases are task specifi  c. Our model may provide a unique 
opportunity to identify a kinase for a specific PECAM-1 
phosphorylation system. Cell models were pretreated for 1 min 
with a kinase inhibitor, stretched or left unstretched for 5 min in 
the presence of the inhibitor, Na  3 VO 4   (a tyrosine phosphatase 
inhibitor) and ATP, and then PECAM-1 phosphorylation levels 
were assayed. For controls, models were stretched without in-
hibitors, with Na  3 VO 4  , or with Na  3 VO 4   and DMSO (solvent for 
inhibitors), all of which exhibited stretch-induced PECAM-1 
phosphorylation. As shown in   Fig. 5 (A and B)  , 100   μ  M genistein, 
  Figure 3.       Increased tyrosine phosphorylation 
in the stretched cell model.   (A) Extracted BAEC 
models were stretched or unstretched for 10 min 
and double labeled with 4G10 and anti  – 
pan-cadherin. Note that cells in the stretched 
monolayer are more clearly outlined by 4G10 
staining than those in the unstretched sample. 
No signiﬁ  cant changes were observed in anti-
cadherin staining before and after stretching. 
Bipolar arrow indicates the direction of stretch. 
Bar, 20   μ  m. (B) BAECs cultured on an elastic 
substrate were treated with Lipofectamine only 
(LF control) or transiently transfected with PECAM-1 
siRNA and then extracted. The extracted models 
were stretched or left unstretched for 5 min at 
37  °  C and their tyrosine phosphorylated pro-
tein levels determined using 4G10 immuno-
blotting. Arrow indicates a 130-kD band whose 
phosphorylation level was diminished in PECAM-1 
siRNA transfected cells.     
  Figure 4.       Stretch-induced PECAM-1 phosphorylation in 
the cell model.   (A) BAEC models were stretched or left 
unstretched for 5 min in the presence or absence of ATP. 
PECAM-1 was immunoprecipitated from solubilized mod-
els and immunoblotted with 4G10 and anti  –  PECAM-1. 
An example of typical immunoblotting data is shown (left). 
Intensity of immunoblotted bands was quantiﬁ  ed and ex-
pressed relative to the PECAM-1 phosphorylation level in 
ATP-treated unstretched samples (right; mean   ±   SEM; 
  n   = 4). Student  ’  s   t   test was used to compare stretched to 
unstretched samples for each category. *, P = 0.0003; 
#, P = 0.1248. (B) BAEC models were stretched for 5 min 
to various extents (% elongation) and immunoprecipitated 
PECAM-1 was immunoblotted with 4G10 and anti  –
  PECAM-1. Levels of phosphorylation were quantiﬁ  ed and 
expressed relative to the PECAM-1 phosphorylation level 
in unstretched cells (mean   ±   SEM). Sample size:   n   = 3 
for 0, 5, 15, and 25%;   n   = 2 for 10 and 20%. Student  ’  s 
  t   test was used to compare stretched to unstretched sam-
ples. *, P = 0.0095, 0.0095, and 0.0049 for 5, 15, 
and 25%, respectively. (C) Cyclic stretch (15%; 1 Hz; 
5 min) induced a 1.53   ±   0.05-fold increase (mean   ±   
SEM;   n   = 3) of PECAM-1 phosphorylation in extracted 
BAEC models. Control chambers were left on the mov-
able shaft of the stretch apparatus without stretching so 
that they were exposed to the same oscillation (motion 
control). Student  ’  s   t   test was used to compare stretched 
to unstretched samples. P = 0.0002. (D) Stretch-induced 
PECAM-1 phosphorylation in intact and extracted HUVEC. 
Student  ’  s   t   test was used to compare stretched to un-
stretched samples. In intact cells, stretch induced a 1.42   ±   
0.18-fold increase (mean   ±   SEM;   n   = 5; P = 0.0273). 
In extracted models, stretch induced a 1.75   ±   0.33-fold 
increase (mean   ±   SEM;   n   = 5; P = 0.0260). Black lines 
indicate that intervening lanes have been spliced out.     757 FYN MEDIATES PECAM-1 MECHANOTRANSDUCTION   • Chiu et al. 
  Fyn, not Src or Yes, is responsible 
for PECAM-1 phosphorylation in 
stretched models 
  Because simple association-based screening could not reduce 
the fi  eld of kinase candidates further, we turned to a molec-
ular biology approach. ECs were treated with Src, Yes, or Fyn 
siRNA, cell models were made and stretched, and PECAM-1 
phosphorylation was assayed. The mean knockdown effi  ciency 
estimated by immunoblotting was 60, 67, and 70% for Src, Yes, 
and Fyn, respectively. For controls, cells were treated with com-
mercially available control siRNA, Lipofectamine treatment 
alone, or two scrambled Fyn siRNAs and assayed for PECAM-1 
phosphorylation by stretch and for expressions of PECAM-1, 
Src, Yes, Fyn, and Fer (  Fig. 6 A  ). None of these treatments neg-
atively affected the results of these assays. Because the lot and 
concentration of the Lipofectamine used were the most critical 
factors for cell viability, monolayer morphology, and transfec-
tion effi  ciency, siRNA results are shown with Lipofectamine 
controls. No signifi   cant inhibition in PECAM-1 phosphory-
lation was noted in the stretched models of Src (  Fig. 6, B and C  ) 
or Yes (  Fig. 6, D and F  ) siRNA-treated cells. These results 
could mean that residual levels of Src and Yes are suffi  cient for 
the stretch-induced PECAM-1 phosphorylation but, as we will 
jcb.200801062/DC1). From this list, we eliminated 29 based on 
their lack of endothelial or blood vessel expression, their lack of 
membrane localization, or their target amino acid specifi  city 
(i.e., serine or threonine kinase).   Table I   shows 17 PP2-sensitive 
tyrosine kinases that could be a PECAM-1 kinase. The table also 
includes data on the effects of other inhibitors on each kinase. 
Because SU6656 inhibited PECAM-1 phosphorylation, any kinase 
that is not signifi  cantly inhibited by this compound cannot be a 
PECAM-1 kinase. In contrast, because imatinib, LFM-A13, and 
VEGFR kinase inhibitor did not inhibit PECAM-1 phosphory-
lation, kinases that are inhibited by these compounds should be 
eliminated. Out of the 17 remaining kinases, our kinase inhibi-
tor screening eliminated all but Fyn, Src, and Yes as possible 
PECAM-1 kinases. 
  We next investigated if these three were present in cell 
models and localized to cell  –  cell contacts. Because Src, Fyn, 
and Yes are members of the Src family kinase and share high 
sequence homology, we used monoclonal antibodies made against 
the unique region of each kinase. Src, Yes, and Fyn were de-
tected in cell models and localized to the cell border in both 
extracted and unextracted ECs (  Fig. 5, C and D  ). Thus, these 
kinases are associated with cell  –  cell contacts in the model, and 
the association is not an artifact of cell extraction. 
  Figure 5.       Kinase inhibitor screening.   (A) BAEC models were pretreated with inhibitors for 1 min at 37  °  C and stretched (25% elongation) or left unstretched 
for 5 min in the presence of inhibitors, Na  3  VO  4  , and ATP. PECAM-1 was immunoprecipitated from solubilized models and immunoblotted with anti  –  PECAM-1 
and 4G10. Note that some inhibitors inhibited PECAM-1 phosphorylation, whereas others did not. Control models were treated with no inhibitor and 
either Na  3  VO  4   or DMSO and Na  3  VO  4  . Black lines indicate that intervening lanes have been spliced out. (B) Quantiﬁ  cation of inhibitor effects on PECAM-1 
phosphorylation. Levels of PECAM-1 phosphorylation relative to unstretched models are shown (mean   ±   SEM;   n   = 3). Student  ’  s   t   test was used to compare 
stretched to unstretched samples for each inhibitor. P = 0.0153 (control), 0.0050 (Na  3  VO  4  ), 0.0117 (DMSO), 0.2800 (genistein), 0.2622 (PP2), 0.0958 
(SU6656), 0.0158 (Imatinib), 0.0085 (LFM-A13), and 0.0202 (VEGFR inhibitor). *, P   <   0.05; **, P   <   0.01. (C) BAEC whole cell lysates (total), cell mod-
els, and detergent-soluble fractions (soluble) were immunoblotted with anti-Src, anti-Yes, or anti-Fyn. Comparable amounts of total protein were loaded in 
each lane as shown by immunoblots for actin. (D) Src, Fyn, and Yes were localized to interendothelial contacts in both intact cells and cell models. HAECs 
were used for Src localization, whereas BAECs were used for Yes and Fyn localization. Bar, 20   μ  m.     JCB • VOLUME 182 • NUMBER 4 • 2008  758
which then phosphorylates PECAM-1. This possibility deserves 
special attention because PECAM-1 was phosphorylated in 
cells overexpressing Fer (  Kogata et al., 2003  ), even though Fer 
was eliminated by the fi  rst level of inhibitor screening. When 
BAECs were treated with Fer siRNA and stretched, PECAM-1 
phosphorylation was unattenuated, showing that Fer plays no 
role in this PECAM-1 response (Fig. S5, available at http://
www.jcb.org/cgi/content/full/jcb.200801062/DC1). The result 
also shows that our inhibitor screening has correctly eliminated 
Fer, providing validity to our approach. When Fyn was knocked 
down by siRNA, PECAM-1 phosphorylation by stretch and 
fl  ow was almost completely inhibited. This suggests that other 
kinases, including undiscovered ones, do not play a major role 
in PECAM-1 phosphorylation by mechanical stresses. Thus, 
  although other kinases may phosphorylate PECAM-1 under 
different circumstances, we conclude that Fyn is the kinase 
responsible for stretch- and fl  ow-induced phosphorylation of 
PECAM-1. 
  When ECs are stretched or exposed to fl  ow, Fyn could be 
activated. To test this possibility, we immunoprecipitated Fyn 
from stretch- and fl  ow-stimulated ECs and performed immuno-
blotting on the precipitates using an anti  –  active Src antibody, 
which is known to recognize active Fyn. As a positive control, 
we treated ECs with hyperosmotic shock, which is known to ac-
tivate Src family kinases (  Cohen, 2005  ), and confi  rmed highly 
increased phosphorylation of Src family kinases by immuno-
blotting with this antibody (unpublished data). However, increased 
phosphorylation at the active site of Fyn was not observed in 
ECs exposed to stretch or fl  ow for 10 min (  Fig. 7 H  ). These re-
sults are consistent with those reported earlier by Sawada et al. 
(  Sawada et al., 2006  ). Although these results support the idea 
discuss in subsequent sections, this is unlikely. When we tested 
models of Fyn siRNA-treated cells, the PECAM-1 response 
was inhibited (  Fig. 6, E and F  ). Because Fyn siRNA-treated 
cells had normal expression of Src and Yes (Fig. S4, available at 
http://www.jcb.org/cgi/content/full/jcb.200801062/DC1), if ei-
ther of them is responsible for the stretch-induced PECAM-1 
phosphorylation, the Fyn knockdown should not have inhibited 
the PECAM-1 response. Thus, the Fyn siRNA experiments ar-
gue against the possibility that residual Src and Yes are capable 
of phosphorylating PECAM-1 in the Src and Yes siRNA-treated 
cell models. These siRNA experiments collectively indicate 
that Fyn, not Src and Yes, is responsible for phosphorylating 
PECAM-1 in stretched cell models. 
  Fyn phosphorylates PECAM-1 in stretch- 
and ﬂ  ow-stimulated ECs 
  To test if Fyn also functions as the sole PECAM-1 kinase in 
stretched intact cells, the siRNA-treated cells were stretched with-
out extraction. ECs with reduced Src or Yes expression failed to 
inhibit stretch-induced PECAM-1 phosphorylation (  Fig. 7, A  –  C 
and E  ). However, Fyn siRNA again disrupted the PECAM-1 
stretch response (  Fig. 7, D and E  ). We used two different Fyn 
siRNA constructs, each targeting a different region of Fyn mRNA, 
and obtained similar inhibitory effects, whereas scrambled Fyn 
siRNA sequences did not reduce Fyn expression nor inhibit 
PECAM-1 response (  Fig. 6 A  ). Furthermore, Fyn knockdown 
also inhibited fl  ow-induced PECAM-1 phosphorylation (  Fig. 7, 
F and G  ). Collectively, our study strongly suggests that Fyn is the 
kinase for stretch- and fl  ow-induced PECAM-1 phosphorylation. 
  Although Fyn can directly phosphorylate PECAM-1, it is 
possible that Fyn  ’  s role is to activate Fer (  Kapus et al., 2000  ), 
  Table I.       Kinase inhibitor screening   
  Kinases    Inhibitors 
  100   μ  M 
Genistein  
  10   μ  M 
PP2  
  1   μ  M 
SU6656  
  10   μ  M 
Imatinib  
  200   μ  M 
LFM-A13  
  1   μ  M 
VEGFR kinase inhibitor 
ABL + +    +
ABL1 E255K + +
ABL1 G250E + +
ABL1 Y253F + +
ABL2 (ARG) + +
BMX +    +
CSK +       
EGFR + +          
ERBB4 (HER4) + +
FGR + +
FLT4 (VEGFR3) +    +
FYN + + +    
KDR (VEGFR2) +    +
PDGFRA D842V + +
PDGFRB +    ++
SRC + + +       
YES + + +    
Listed are tyrosine kinases that are PP2 sensitive, expressed in arterial ECs, and likely localized to cell  –  cell contacts. Their susceptibility to other inhibitors is indicated. 
    , inhibition by   <  60% ; +, inhibition by   >  60%; blank, no data available. PECAM-1 response was inhibited by Genistein, PP2, and SU6656 and was not inhibited 
by Imatinib, LFM-A13, and VEGFR kinase inhibitor (  Fig. 5, A and B  ). Kinase susceptibility is obtained from the following sources: Genistein,   Akiyama and Ogawara 
(1991)  ; PP2 and Imatinib, http://www.invitrogen.com/downloads/SelectScreen_Data_193.pdf; SU6656,   Blake et al. (2000)  ; LFM-A13,   Chau et al. (2002)   and 
  Mahajan et al. (1999)  ; and VEGFR kinase inhibitor,   Cools et al. (2004)   and   Fraley et al. (2002)  .759 FYN MEDIATES PECAM-1 MECHANOTRANSDUCTION   • Chiu et al. 
tect this. Although this possibility cannot be excluded, our re-
sults show that Fyn is constitutively active at a signifi  cant level 
in unstimulated cells, suggesting that the early phase of the 
that mechanical stress does not activate Fyn, it remains possi-
ble that a small fraction of Fyn that is critical for PECAM-1 
phosphorylation is activated and that our assay is unable to de-
  Figure 6.       Fyn is essential for the PECAM-1 mechanoresponse in cell models.   (A) Controls for siRNA experiments. ECs cultured on an elastic substrate 
were transiently transfected with Lipofectamine 2000 alone, negative control siRNA, or scrambled siRNAs, stretched in the presence of Na  3  VO  4   for 
10 min, and PECAM-1 tyrosine phosphorylation was assayed (top). Compared with unstretched ECs under each condition, stretched cells exhibited increased 
PECAM-1 phosphorylation by 1.42   ±   0.08- (LF only;   n   = 6), 1.84   ±   0.15- (control siRNA;   n   = 4), 1.69   ±   0.17- (scrambled siRNA-2;   n   = 3), and 1.49   ±   
0.09- (scrambled siRNA-1;   n   = 3) fold (mean   ±   SEM). Student  ’  s   t   test was used to compare stretched to unstretched values. *, P = 0.0002 (LF control), 
0.001 (control siRNA), 0.047 (scrambled siRNA-2), and 0.004 (scrambled siRNA-1). The bottom shows the expression of PECAM-1, Src, Yes, and Fyn in 
whole cell lysates by immunoblotting using actin as a loading control. Although not depicted here, Fer expression was not altered by these control siRNAs. 
(B  –  F) ECs cultured on an elastic substrate were transiently transfected with Src, Yes, or Fyn siRNA or Lipofectamine 2000 alone, and cell models were made 
after they formed conﬂ  uent monolayers. Models were stretched or left unstretched for 5 min at 37  °  C in the presence of ATP and Na  3  VO  4  , and PECAM-1 
phosphorylation was assayed. Each kinase associated with the cell model was checked by immunoblotting, using the level of actin as a loading control. 
(B and C) PECAM-1 phosphorylation was not suppressed in HAEC models with reduced Src expression. PECAM-1 phosphorylation levels are shown rela-
tive to unstretched models (mean   ±   SEM;   n   = 3). Student  ’  s   t   test was used to compare stretched to unstretched values. *, P = 0.0124 (LF control) and 0.0292 
(Src siRNA). (D) PECAM-1 phosphorylation was not suppressed in BAEC models with reduced Yes expression. (E) Suppressed PECAM-1 phosphorylation in 
BAEC models with reduced Fyn expression is shown. (F) Levels of PECAM-1 phosphorylation in Yes and Fyn siRNA experiments are quantiﬁ  ed and shown 
relative to unstretched models (mean   ±   SEM;   n   = 5). Student  ’  s   t   test was used to compare stretched to unstretched values. *, P = 1.7   ×  10 
    7   (LF control) and 
0.0032 (Yes siRNA); #, P = 0.1665. Black lines indicate that intervening lanes have been spliced out.     JCB • VOLUME 182 • NUMBER 4 • 2008  760
in the presence of ATP, indicating that the model contains mole-
cules that are needed for this stretch-activated phosphorylation 
reaction. What is not known is whether or not the complete 
phosphorylation machinery is preserved in the model. For ex-
ample, it is possible that this in vitro system has lost certain 
regulatory mechanism and, thus, the model is unregulated. 
However, it is reasonable to assume that proteins that are mini-
mally needed for PECAM-1 phosphorylation by stretch are in 
mechanostress-induced PECAM-1 phosphorylation by Fyn is 
equally possible without robustly activating this kinase. 
  Discussion 
  PECAM-1 and mechanotransduction 
  Our study has demonstrated that PECAM-1 can be phosphory-
lated when detergent-extracted EC monolayer models are stretched 
  Figure 7.       Fyn mediates stretch- and ﬂ  ow-elicited PECAM-1 phosphorylation in ECs.   ECs cultured on an elastic substrate were transiently transfected with 
Src, Yes, or Fyn siRNA or Lipofectamine 2000 alone. When conﬂ  uent monolayers were formed, cells were stretched in the presence of Na  3  VO  4   for 10 min 
and PECAM-1 tyrosine phosphorylation was assayed. Expression of each kinase was checked in whole cell lysates by immunoblotting using actin as 
a loading control. (A) PECAM-1 phosphorylation was not suppressed in HAECs transfected with Src siRNA. (B) Levels of PECAM-1 phosphorylation in 
Src siRNA-treated HAECs are quantiﬁ  ed and shown relative to unstretched cells (mean   ±   SEM;   n   = 4). Student  ’  s   t   test was used to compare stretched to 
unstretched values. *, P = 0.0315 (LF control) and 0.0264 (Src siRNA). (C) Reduced expression of Yes in BAECs did not suppress PECAM-1 phosphory-
lation. (D) PECAM-1 phosphorylation was suppressed in BAECs transfected with two different Fyn siRNAs. (E) Levels of PECAM-1 phosphorylation in Yes 
and Fyn siRNAs treated cells are quantiﬁ  ed and shown relative to unstretched cells (mean   ±   SEM). The sample sizes are   n   = 4 for Lipofectamine control 
and Yes siRNA,   n   = 3 for Fyn siRNA-2, and   n   = 5 for Fyn siRNA-1. Student  ’  s   t   test was used to compare stretched to unstretched values for each category. 
*, P = 0.0002 (Lipofectamine control) and 9.8   ×   10 
    7   (Yes siRNA). #, P = 0.1493 (Fyn siRNA-2) and 0.4875 (Fyn siRNA-1). (F) Conﬂ  uent BAECs tran-
siently transfected with Fyn siRNA or Lipofectamine 2000 alone were subjected to ﬂ  ow (24 dyn/cm 
2  ) in the presence of Na  3  VO  4   for 10 min at 37  °  C, and 
PECAM-1 phosphorylation was assayed. Flow-induced PECAM-1 phosphorylation was suppressed in Fyn siRNA-treated cells. (G) Quantiﬁ  ed results of 
ﬂ  ow experiments were expressed as the mean   ±   SEM (  n   = 4). Student  ’  s   t   test was used to compare shear stressed to static control values. *, P = 0.0311; 
#, P = 0.0532. (H) Fyn activity was analyzed in BAECs subjected to stretch or ﬂ  ow for 10 min by immunoprecipitation with anti-Fyn and immunoblot with 
antibodies that recognize the active form of Src family kinases (pY418 SFK). Note that mechanical stress does not increase Fyn activity. Note also that Fyn 
is active in unstimulated (unstretched and static) cells. One of three independent experimental results is depicted. Black lines indicate that intervening lanes 
have been spliced out.     761 FYN MEDIATES PECAM-1 MECHANOTRANSDUCTION   • Chiu et al. 
gest that PECAM-1 and Fyn are important molecules in a 
mechanotransducer complex located at cell  –  cell contacts. 
 There are mechanosignaling events that depend on PECAM-1 
expression such as Src phosphorylation and integrin activation by 
fl  uid shear stress ( Tzima et al., 2005 ). This PECAM-1 – dependent 
Src phosphorylation was reported to reach the maximum level 
within 15 s of fl  ow stimulation, which is much sooner than an 
increase in PECAM-1 phosphorylation can be reliably detected. 
If the Src phosphorylation by fl  ow requires PECAM-1 phosphory-
lation, it might be achieved by the fraction of PECAM-1 that is 
constitutively phosphorylated. Another possibility is that when 
the fi  rst molecules of PECAM-1 are phosphorylated by fl  ow, 
which should take place immediately after fl  ow stimulation, 
a mechanism for Src phosphorylation is fully activated, result-
ing in the robust activation of Src. A more interesting possibil-
ity, however, is that Src phosphorylation does not depend on 
PECAM-1 phosphorylation. This hypothesis suggests PECAM-1 
to be involved in two different mechanosignaling pathways, 
one PECAM-1 phosphorylation-dependent and one PECAM-1 
phosphory lation-independent  pathway. 
  Mechanical response of in vitro models 
  The use of a detergent-extracted cell model is an important as-
pect of this study. Not only did it simplify the system but it also 
allowed us to use various inhibitors effectively. When an inhibi-
tor is used with intact cells, one always wonders what the con-
centration of the inhibitor is inside them. This ambiguity is 
practically absent when a cell model is exposed to inhibitors. 
In addition, because the effi  cacy data available from the database 
is based on in vitro assays where inhibitors have free access to 
target kinases, it is important for our system to be studied with 
inhibitors under the same barrier-free condition. Several recent 
studies on mechanotransduction have successfully used cell mod-
els to elucidate certain molecular mechanisms for mechanically 
induced protein – protein interactions and protein phosphorylation 
(  Sawada and Sheetz, 2002  ;   Tamada et al., 2004  ;   Sawada et al., 
2006  ). Our study has added a new dimension, inhibitor screening 
combined with the siRNA technique, to the use of cell models in 
the study of mechanotransduction. 
  Kinase screening 
  In this study, we used kinase inhibitors to make a short list of 
possible PECAM-1 kinases and then siRNA to identify Fyn as 
the PECAM-1 kinase. The same general approach may be appli-
cable to other studies in which a specifi  c kinase or enzyme is to 
be identifi  ed. For example, stretch-induced tyrosine phosphory-
lation of proteins associated with focal adhesion in detergent-
extracted fi  broblast models was reported (  Tamada et al., 2004  ), 
but the study did not identify specifi  c kinases for the response. 
This would be an excellent system to which the present strategy 
could be applied. Kinases are particularly good targets because 
a suffi  ciently large database is available for kinase inhibitors. 
For effective screening, it is essential to select a set of inhibitors, 
some of which do and others of which do not inhibit a partic-
ular biological process under investigation. With an appropriate 
combination of positive and negative inhibitors, one can come 
up with a short list of possible kinases, which then may be 
the model. It is also reasonable to assume that the stretch-
  induced PECAM-1 phosphorylation reaction occurs without the 
soluble components of the cell and the plasmalemmal function 
that regulates ionic events across the membrane, although 
they could still play roles in fi  ne-tuning the reaction. Using this 
model system, we identifi  ed Fyn as the kinase for stretch-
  induced PECAM-1 phosphorylation, and using siRNAs, we fur-
ther demonstrated that Fyn was the primary kinase responsible 
for PECAM-1 phosphorylation in intact ECs exposed to stretch 
as well as shear stress. 
  It is not yet clear how Fyn and PECAM-1 interact in a 
mechanostress-dependent manner. The fact that PECAM-1 
phosphorylation is achievable in the model appears to suggest 
Fyn and PECAM-1 to be closely positioned, and the two mole-
cules interact when mechanical forces are applied. This could 
involve certain structural changes, as we had suggested in our 
earlier study (  Osawa et al. 2002  ). Another possibility is that Fyn 
located near the PECAM-1 phosphorylation sites is activated 
when the model is stretched. Highly localized activation of Fyn 
that our assay cannot detect remains as a possibility, but our 
study has shown that stretch and fl  ow do not signifi  cantly elevate 
Fyn activity in ECs within the time scale of our experiments and 
that a portion of Fyn appears to be constitutively active. Thus, Fyn 
activation may not be necessary. A third possibility is that mech-
anostress causes already active Fyn to diffuse a small distance to 
phosphorylate PECAM-1. This diffusion-dependent phosphory-
lation may be slow and ineffi  cient so that it may take some 
time for the assay system to detect an increase in PECAM-1 
phosphorylation. It is of course also plausible that any combina-
tions of these possibilities occur simultaneously. At present, the 
precise molecular mechanism for the mechanostress-induced 
Fyn – PECAM-1  interaction  remains  elusive. 
  The presence of a supramolecular complex that converts 
mechanical force into biochemical reactions at cell  –  cell con-
tacts has been proposed (  Osawa et al., 2002  ;   Davies et al., 2003  ; 
  Chiu et al., 2004  ;   Tzima et al., 2005  ;   Liebner et al., 2006  ), but 
its molecular makeup remains largely unknown. Our earlier ex-
periments, in which PECAM-1 phosphorylation was achieved 
by a direct application of pulling force onto PECAM-1 which 
then caused ERK activation, suggest that PECAM-1 converts 
the mechanical force into biochemical energy (i.e., phosphory-
lated form of PECAM-1) which then activates intracellular sig-
naling (  Osawa et al., 2002  ). In this regard, PECAM-1 may be a 
mechanotransducer of the hypothesized mechanoresponsive pro-
tein complex. The present study suggests that Fyn as the PECAM-1 
kinase is an important component of the mechanotransducer 
complex. Indeed, small but detectable amounts of Fyn were 
  coimmunoprecipitated with PECAM-1 from platelets (  Cicmil 
et al., 2000  ;   Ohmori et al., 2001  ), and we also identifi  ed a small 
amount of Fyn in anti  –  PECAM-1 immunoprecipitates from EC 
extracts (unpublished data). We wondered if the association 
between Fyn and PECAM-1 might increase in ECs exposed to 
stretch, but we were unable to reliably quantify the level of Fyn  –
  PECAM-1 coimmunoprecipitation because the amount of Fyn 
coimmunoprecipitated with PECAM-1 at any time point during 
stretch stimulation was barely above the limit of detection (un-
published data). Nonetheless, our past and present studies sug-JCB • VOLUME 182 • NUMBER 4 • 2008  762
  siRNA transfection 
  Src, Yes, PECAM-1, and scrambled siRNAs were synthesized by Integrated 
DNA Technologies, whereas Fyn and Fer siRNAs were made by Ambion. 
Two Fyn siRNA constructs (Fyn-1 and Fyn-2) and their respective sequence-
scrambled siRNA constructs were used to establish the biological speci-
ﬁ  city of Fyn knockdown. ECs were plated 24 h before transfection on 
collagen-coated silicone chambers at a cell density of     70  –  80% conﬂ  u-
ency. siRNA and Lipofectamine 2000 were diluted in Opti-MEM and 
added to cells according to the manufacturer  ’  s instructions. For controls, 
cells were treated with Lipofectamine 2000 alone, certiﬁ  ed negative con-
trol siRNA (QIAGEN), or the scrambled siRNAs described in this section. 
After 52  –  56 h of transfection, conﬂ   uent monolayers were subjected to 
stretch. Certiﬁ  ed negative control siRNA was used at 20 nM. Other siRNA 
sequences and concentrations used for transfection were the following: 
human Src, AAGCAACUUGCCCAGCUAUGA (15 nM;   Werdich and 
Penn, 2005  ); bovine Yes, UUAUGAAGCUAGAACUACA (5 nM;   Hirsch et al., 
2005  ); bovine Fyn-1, GGAAGUUUACUCGAUUUCU (10 nM); scrambled 
siRNA-1, GCUAAGCUACGUUAUUGUU (10 nM); bovine Fyn-2, GGA-
CAAAGAAGCAACAAAA (10 nM); scrambled siRNA-2, GAAAGACGA-
CAAACAAAGA (10 nM); bovine Fer, GGCACUGGGUUUUCAAAUA 
(20 nM); and bovine PECAM-1, GGAGGAACACAGAGAGAGUUAU 
(12.5 nM;   Tai et al., 2005  ). 
  Immunoprecipitation and immunoblotting 
  Cells were washed with ice-cold PBS, lysed with lysis buffer (50 mM Tris-
HCl, pH 7.4, 150 mM NaCl, 1% Triton X-100, 2 mM Na  3  VO  4  , and 1% 
protease inhibitor cocktail), and the lysate was centrifuged at 18,000   g   for 
15 min at 4  °  C. 100   μ  L of the supernatant was incubated with 1   μ  g of anti  –
  bovine PECAM-1 or anti  –  human PECAM-1 for 16 h at 4  °  C with continuous 
mixing. The immunocomplex was incubated with protein A  –  conjugated 
agarose beads (Millipore) for 3 h at 4  °  C with constant agitation and col-
lected by centrifugation. Beads were washed three times with lysis buffer, 
and the bound material was eluted with SDS sample buffer, subjected to 
8% SDS-PAGE, and electrotransferred to a nitrocellulose membrane. Immuno-
precipitated PECAM-1 was immunoblotted with anti-phosphotyrosine (4G10) 
and anti  –  PECAM-1 and IRDye-conjugated secondary antibodies. Two-color 
Western blot ﬂ  uorescent signals were detected with the Odyssey Infrared 
Imaging System (LI-COR Biosciences). 
  Quantiﬁ  cation of PECAM-1 phosphorylation and statistics 
  All the samples to be quantiﬁ  ed from a set of experiments were handled to-
gether as a unit for immunoprecipitation, SDS-PAGE, and immunoblotting. 
Using the two-color Western blot technique and the Odyssey software, the 
intensity of anti  –  protein phosphotyrosine (4G10) and anti  –  PECAM-1 immuno-
blotting was measured on the same blot at the same time. The level of 
PECAM-1 phosphorylation was determined by the ratio of phosphotyrosine 
to PECAM-1 staining. The value obtained from unstretched conﬂ  uent cells 
was taken as 1 and other values were expressed relative to this. Student  ’  s 
  t   test (one-tailed distribution, equal variance, pairwise comparisons) was 
used to determine levels of signiﬁ  cance. P-values   <  0.05 were considered 
to be signiﬁ  cant. 
  Fluorescence microscopy 
  Cells were ﬁ  xed with 3.7% formaldehyde in PBS for 10 min and permeabi-
lized with 0.1% Triton X-100 in PBS for 1 min at room temperature. Cell models 
were ﬁ   xed similarly but no permeabilization procedure was employed. 
Antibodies against PECAM-1, protein phosphotyrosine, and pan-cadherin 
were diluted in PBS containing 0.05% Tween 20. Antibodies against Src, 
Fyn, and Yes were diluted in TBS containing 2% BSA, and 0.1% Tween 20. 
Samples were treated with the appropriately diluted primary antibodies 
for 1 h at room temperature and washed several times with PBS or TBS. 
Secondary antibodies labeled with Alexa 546 or Alexa 488 were then 
used to visualize the bound primary antibodies. Control staining was done 
using either nonimmune IgG as the primary antibody or staining sam-
ples with the secondary antibodies alone. Images were observed using 
an epi-ﬂ  uorescence microscope (BX51; Olympus) equipped with a cam-
era (RT color Spot; Diagnostic Instruments, Inc.) operated by the camera 
software (Version 3.5.9.1 for Mac OS), using a 60  ×   0.9 NA water immer-
sion or 1.4 NA oil immersion lens. Minor image contrast adjustment was 
done using Photoshop (Adobe). 
  Scanning electron microscopy 
  BAECs grown on collagen-coated coverslips were ﬁ  xed with 2% glutaral-
dehyde overnight with or without prior detergent extraction. They were 
then dehydrated, critical-point dried, and coated with gold in a routine 
screened further by other means. Due to the possible inhibitor 
concentration differential across the plasma membrane, this ap-
proach is more applicable to cell-free systems than living cells. 
A caveat is that the strategy can only be applied to known 
kinases. Unknown or novel kinases or those for which little to 
no data are available in the database cannot be studied by this 
approach. However, this problem should become less of an issue 
as the information in inhibitor databases expands. 
  Materials and methods 
  Reagents 
  For culturing cells, DME, penicillin/streptomycin, and Trypsin/EDTA solu-
tion were purchased from Mediatech, Inc., medium 200 and low serum 
growth supplement from Cascade Biologics, and FBS from Equitech-Bio, 
Inc. Other reagents purchased include Lipofectamine 2000 (Invitrogen), 
collagen type I (BD Biosciences), genistein (EMD), LFM-A13 (EMD), SU6656 
(EMD), VEGFR kinase inhibitor (3-(3-Thienyl)-6-(4-methoxyphenyl)pyrazolo-
pyrimidine; EMD), and PP2 (Tocris Bioscience). Imatinib was kindly pro-
vided by Novartis. Rabbit polyclonal antibodies against human PECAM-1 
(C-20), Fyn (clone Fyn3), and Fer (H-180) were obtained from Santa Cruz 
Biotechnology, Inc., rabbit anti-Src[pY418] from Invitrogen, and rabbit 
anti  –  pan-cadherin from Invitrogen. The following mouse monoclonal anti-
bodies were purchased: anti  –  protein phosphotyrosine (clone 4G10) and 
anti-Src (clone GD11; Millipore); anti-c-Yes and anti-Fyn (BD Biosciences); 
and anti-actin (clone AC-40; Sigma-Aldrich). Fluorescently labeled second-
ary antibodies used include IRDye 800  –  conjugated anti  –  mouse IgG (Rock-
land), IRDye 680  –  conjugated anti  –  rabbit IgG (Rockland), Alexa Flour 
488  –  labeled goat anti  –  mouse IgG (Invitrogen), and Alexa Flour 546-  –
    labeled goat anti  –  rabbit IgG (Invitrogen). Antibodies against bovine 
PECAM-1 cytoplasmic domain were made and described previously (  Osawa 
et al., 2002  ). 
  Cells and mechanical stimulation 
  BAECs were purchased from Clonetics, cultured in DME (1 g/liter glucose) 
supplemented with 10% FBS and penicillin/streptomycin (50 IU/ml and 
50   μ  g/ml) at 37  °  C and 5% CO  2  , and used between passages six and 
nine. HAECs were purchased from Cascade Biologics and used between 
passages two and four. HUVECs were kindly provided by Z.-G. Jin and 
C. Wong (Aab Cardiovascular Research Institute, University of Rochester, 
Rochester, NY) and used between passages three and eight. Both HAECs 
and HUVECs were cultured in Medium 200 supplemented with 5% FBS, 
2% low serum growth supplement, and penicillin/streptomycin (50 IU/ml 
and 50   μ  g/ml) at 37  °  C and 5% CO  2  . 
  The stretch apparatus was described previously (  Shi et al., 2007  ) 
and operated in either a cyclic or single sustained stretch mode. Silicone 
chambers were coated by adding and then evaporating 2 ml of 100   μ  g/ml 
Type I collagen in 0.02 N acetic acid at room temperature overnight, UV 
sterilized, and rinsed ﬁ  ve times with PBS. ECs (2  –  3   ×   10 
5   cells) were plated 
on the collagen-coated surface (30   ×   30 mm 
2  ) and cultured for 2  –  3 d 
to reach conﬂ  uence. To stimulate ECs with shear stress, cells were grown to 
conﬂ  uency in a gelatin-coated 60-cm Petri dish for 2  –  3 d and exposed to 
24 dyn/cm 
2   of ﬂ  uid shear stress using a cone-and-plate type of shear stress 
apparatus (  Tai et al., 2005  ). 
  Detergent-extracted cell model 
  A monolayer of ECs was washed once with ice-cold TBS(+) (20 mM Tris, 
pH 7.6, 137 mM NaCl, 2 mM MgCl  2  , and 2 mM CaCl  2  ), and treated 
with 0.1% Triton X-100 in TBS(+) supplemented with 1 mM DTT, 0.2 mM 
ATP, 1 mM phenylmethylsulphonyl ﬂ  uoride, 10   μ  g/ml aprotinin, 10   μ  g/ml 
pepstatin, and 10   μ  g/ml leupeptin on ice with gentle agitation for 90 s 
After extraction, the detergent-containing buffer was removed and the 
chamber was gently rinsed once with TBS(+). The model was then incu-
bated with Buffer I (TBS(+) containing 2 mM Na  3  VO  4  , 0.5 mM ATP, 1 mM 
phenylmethylsulphonyl ﬂ  uoride, 10   μ  g/ml aprotinin, 10   μ  g/ml pepstatin, 
and 10   μ  g/ml leupeptin) and immediately subjected to stretch or left un-
stretched at 37  °  C. For kinase inhibitor studies, immediately after extraction, 
models were incubated for 1 min at 37  °  C with inhibitors (stock solutions 
made in DMSO except for imatinib which was dissolved in water) in 
Buffer I without ATP and Na  3  VO  4  . After this pretreatment, 0.5 mM ATP 
and 2 mM Na  3  VO  4   were added and the models were stretched or left un-
stretched for 5 min at 37  °  C. 763 FYN MEDIATES PECAM-1 MECHANOTRANSDUCTION   • Chiu et al. 
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